Amid a broad market rally that pushed the Dow and S&P 500 to new record highs, several companies saw significant growth. In the biotechnology sector, Legend Biotech (NASDAQ: LEGN) increased by 42.22%, adding $10.77 to its price to close at $36.28. Legend Biotech is a clinical-stage company developing cell therapies for cancer, with its main product targeting multiple myeloma.
In financial services, leveraged Exchange-Traded Funds (ETFs) tracking Marvell Technology performed strongly. Direxion Daily Marvell Technology Bull 2X Shares (NASDAQ: MRVU) rose 65.11% to $249.02, and Direxion Daily Marvell Technology Bear 2X Shares (NASDAQ: MVLL) climbed 65.00% to $189.40. These ETFs are designed to provide 200% of the daily return of Marvell Technology's stock, amplifying its movements. This follows Direxion's launch of new single-stock ETFs.
Technology company VIDA (NASDAQ: VIDA), which recently went public, surged 53.46% to $5.54. This growth is supported by its new partnership with Telinta. The deal integrates VIDA’s AI agent operating system into Telinta’s telecom platform, expanding its market reach and demonstrating growing interest in AI business solutions.
In summary, today's top market gainers were driven by clear catalysts. Positive earnings reports, strategic partnerships, and the launch of new financial products were key factors behind the substantial growth seen across these diverse companies.
